Intensity Therapeutics, Inc. (INTS) stock
INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.28+0.19 (+6.15%)
Close on Nov 11, 2026Market cap $10.71MP/E –Yield –
Intensity Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Intensity Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 2.7× a year earlier. Over the last 3 years it ranged from 1.0× to 21.7×, with a median of 4.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −1.7 |
| 2025 | Dec 31, 2025 | 2.8× | −6.0 |
| 2024 | Dec 31, 2024 | 8.8× | +1.4 |
| 2023 | Dec 29, 2023 | 7.4× | – |
See a number that looks wrong?